Incyte's blood cancer therapy meets main goal in late-stage trial
05/01/2026 12:35
Jan 5 (Reuters) - Incyte INCY.O said on Monday its experimental combo therapy met the main goal in a late-stage trial testing patients with a type of blood cancer. (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Incyte
See all newsIncyte Corp reports results for the quarter ended September 30 - Earnings Summary
Incyte Q3 adjusted loss per share beats estimates
Revolution Medicines falls after Incyte posts competitive pancreatic cancer data
Factbox: Pharma sector doubles down on AI to slash costs, timelines
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler